Skip to main content
    U

    Ultralife Corporation (ULBI)

    Official site

    INDUSTRIALS • ELECTRICAL EQUIPMENT & PARTS • NASDAQ

    $15.68
    -0.05 (-0.32%)

    Market Cap: $262.13M

    Last updated: Nov 17, 2026 at 11:02 AM ET

    Ultralife Corporation (ULBI) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Ultralife reported revenue of $191.16M for the fiscal year ended Dec 31, 2025, up 16.2% from the year before. That year, net income was -$5.95M with a net margin of -3.1%, operating cash flow was $10.99M and free cash flow was $7.12M. The quarter ended Sep 30, 2026 had revenue of $48.27M and net income of $2.38M.

    Revenue and Margins

    The operating margin was -3.1% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue grew from $82.46M, a compound annual rate of 9.8%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$191.16M+16.2%24.1%-3.1%-3.1%
    Dec 2024$164.46M+3.7%25.7%6.1%3.9%
    Dec 2023$158.64M+20.3%24.7%6.0%4.5%
    Dec 2022$131.84M+34.2%22.3%0.1%-0.1%
    Dec 2021$98.27M-8.8%25.1%0.0%-0.2%
    Dec 2020$107.71M+0.9%27.1%5.3%4.9%
    Dec 2019$106.80M+22.5%29.2%6.9%5.0%
    Dec 2018$87.19M+1.9%29.3%7.5%28.7%
    Dec 2017$85.53M+3.7%30.7%7.6%9.0%
    Dec 2016$82.46MN/A30.4%4.6%4.2%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the company posted a net loss after a profit the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$191.16M$164.46M$158.64M$131.84M$98.27M$107.71M$106.80M$87.19M$85.53M$82.46M
    Cost of revenue$145.14M$122.14M$119.44M$102.44M$73.63M$78.55M$75.63M$61.61M$59.30M$57.35M
    Gross profit$46.02M$42.31M$39.20M$29.40M$24.64M$29.16M$31.16M$25.58M$26.23M$25.11M
    Research and development$10.40M$8.27M$7.53M$7.08M$6.83M$5.95M$6.80M$4.51M$4.74M$5.95M
    Operating income-$5.90M$9.96M$9.47M$129.00K$35.00K$5.70M$7.37M$6.55M$6.48M$3.76M
    Net income-$5.95M$6.41M$7.17M-$120.00K-$230.00K$5.33M$5.31M$25.00M$7.66M$3.48M
    EBITDA$1.32M$14.49M$15.11M$5.00M$3.73M$10.45M$10.10M$9.08M$8.96M$6.64M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$48.27M$47.94M$47.45M$48.48M$43.37M$48.56M$50.75M$43.85M$35.69M$42.98M$41.93M$44.55M
    Gross profit$13.29M$13.87M$10.11M$12.06M$9.62M$11.60M$12.74M$10.60M$8.68M$11.56M$11.47M$11.40M
    Operating income$3.19M$3.44M-$215.00K-$10.61M-$951.00K$2.26M$3.40M$1.47M$511.00K$3.92M$4.06M$3.65M
    Net income$2.38M$2.52M-$471.00K-$7.45M-$1.25M$870.00K$1.88M$233.00K$279.00K$2.99M$2.90M$2.85M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $49.65M exceeded cash and equivalents by $40.31M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$216.91M$220.45M$178.28M$168.43M$159.54M$137.70M$144.56M$120.85M$97.19M$84.74M
    Current assets$105.80M$97.16M$90.20M$78.99M$66.52M$64.50M$70.37M$67.16M$61.92M$49.42M
    Cash and equivalents$9.35M$6.85M$10.28M$5.71M$8.41M$10.65M$7.41M$25.93M$18.24M$10.63M
    Total liabilities$86.78M$86.26M$52.85M$52.03M$41.80M$20.78M$34.81M$16.39M$18.14M$16.88M
    Short-term debt$4.13M$2.75M$2.00M$2.00M$2.00M$1.36M$1.37M$0$0$0
    Long-term debt$45.53M$51.50M$23.62M$19.31M$18.86M$0$15.78M$0$0$0
    Shareholder equity$130.00M$134.00M$125.33M$116.28M$117.62M$116.80M$109.73M$104.55M$79.20M$68.03M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$224.40M$216.16M$220.63M$216.91M$222.25M$220.96M$223.75M$220.45M$172.44M$169.82M$180.55M$178.28M
    Total liabilities$89.77M$83.56M$90.89M$86.78M$84.81M$82.32M$87.15M$86.26M$37.81M$36.47M$51.61M$52.85M
    Cash and equivalents$8.63M$6.66M$8.89M$9.35M$9.26M$10.94M$8.72M$6.85M$6.77M$6.69M$10.10M$10.28M
    Shareholder equity$134.53M$132.51M$129.63M$130.00M$137.26M$138.45M$136.40M$134.00M$134.48M$133.21M$128.84M$125.33M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 64.8% of operating cash flow.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$10.99M$16.64M$1.93M-$1.26M$4.33M$21.72M-$2.97M$10.89M$7.27M$7.65M
    Capital expenditures$3.87M$1.93M$2.55M$1.68M$2.81M$3.10M$6.28M$4.18M$1.39M$1.22M
    Free cash flow$7.12M$14.70M-$623.00K-$2.94M$1.51M$18.62M-$9.25M$6.70M$5.88M$6.43M
    Dividends paidN/AN/AN/A$15.00K$250.00K$148.00K$930.00K$0$0$0
    Share repurchasesN/AN/AN/AN/AN/AN/A$1.96M$742.00K$0$607.00K
    Investing cash flow-$3.87M-$49.95M-$2.55M-$1.68M-$26.33M-$2.98M-$31.53M-$4.18M-$1.39M-$11.08M
    Financing cash flow-$4.68M$29.86M$5.49M$518.00K$19.64M-$15.69M$16.12M$1.17M$1.40M-$175.00K
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$2.93M$1.19M$2.26M$1.49M$198.00K$5.93M$3.37M$3.05M$4.75M$8.93M-$81.00K$2.43M
    Capital expenditures$591.00K$453.00K$770.00K$882.00K$995.00K$1.10M$895.00K$606.00K$594.00K$360.00K$372.00K$1.00M
    Free cash flow-$3.52M$735.00K$1.49M$607.00K-$797.00K$4.83M$2.47M$2.44M$4.15M$8.56M-$453.00K$1.43M
    Last 12 quarters

    Frequently Asked Questions About ULBI

    What is Ultralife's annual revenue?

    Ultralife reported revenue of $191.16M for the fiscal year ended Dec 31, 2025.

    How fast is Ultralife's revenue growing?

    Revenue was up 16.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 13.2%.

    Is Ultralife profitable?

    No. Ultralife reported net income of -$5.95M for the fiscal year ended Dec 31, 2025, with a net margin of -3.1%.

    How much free cash flow does ULBI generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $10.99M minus capital expenditures of $3.87M produced free cash flow of $7.12M.

    How much debt does Ultralife have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $45.53M, short-term debt of $4.13M and cash and equivalents of $9.35M.